One study demonstrated that interleukin-1β, secreted by tumor-associated macrophages (TAMs), might increase the availability of β-catenin via the phosphorylation of GSK3β in colon cancer cells, thereby disrupting the function of the β-catenin destruction complex (71). Here, GSK3B is linked to neoplasm.